The translational paradox of AI in hepatocellular carcinoma: from algorithmic over-engineering to real-world clinical utility - Quiz - MDSpire

The translational paradox of AI in hepatocellular carcinoma: from algorithmic over-engineering to real-world clinical utility

  • By

  • Chen Li

  • Yuka Yanase

  • Ming-Quan Pang

  • May 20, 2026

  • 0 min

Share

Original Source(s)

The translational paradox of AI in hepatocellular carcinoma: from algorithmic over-engineering to real-world clinical utility

  • by Chen Li, Yuka Yanase, Ming-Quan Pang

  • May 20, 2026

Related Content

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease

PD-1 inhibitor combined with chemoradiotherapy in two cases of ovarian cancer brain metastases: a case report

Characteristics and risk factors of immune-related adverse events in patients receiving immune checkpoint inhibitor combination therapy